Exploring coronary artery disease progression using radial wall strain
Natural History of Coronary Atherosclerosis Based on Multimodal Imaging and Physiological Fusion Techniques (NASCENT)
This study is testing if a new way to measure heart artery strain can help predict how quickly heart disease gets worse in people who recently had a heart attack.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 125 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | China National Center for Cardiovascular Diseases Government |
| Locations | 1 site (Beijing) |
| Trial ID | NCT06040073 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the predictive value of radial wall strain (RWS) derived from angiograms for the progression of coronary artery lesions compared to lesion vulnerability assessed by optical coherence tomography (OCT). It involves a multicenter, prospective cohort of individuals who have experienced an acute myocardial infarction within the last 45 days. The study aims to determine if RWS can effectively predict disease progression at one year, using a specific threshold for identifying vulnerable lesions. The findings may help optimize strategies for identifying high-risk plaques in patients.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have had an acute myocardial infarction within the last 45 days and are scheduled for coronary angiography.
Not a fit: Patients with cardiogenic shock, those who are pregnant, or individuals with a life expectancy of less than one year for non-cardiac causes may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the ability to predict coronary artery disease progression, leading to better patient management and outcomes.
How similar studies have performed: While the approach of using radial wall strain is relatively novel, similar studies utilizing optical coherence tomography have shown promise in assessing lesion vulnerability.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * General Inclusion Criteria: 1. Age ≥18 years 2. Acute myocardial infarction ≤ 45 days 3. Planned coronary angiography examination or potential interventional treatment * Angiographic Inclusion Criteria: 1. The presence of at least 1 non-flow-restricting lesion (visually estimated diameter stenosis: 30%-80%; QFR \> 0.80) in any non-infarct related artery with RVD ≥2.5 mm by visual assessment Exclusion Criteria: * General exclusion Criteria: 1. Cardiogenic shock 2. Pregnant or woman of child-bearing potential 3. Life expectancy less than 1 year for non-cardiac causes 4. Unable to tolerate contrast agents or anticoagulant/antiplatelet therapy 5. Prior CABG or planned CABG * Angiographic exclusion Criteria: 1. Poor angiographic image quality precluding vessel contour detection or with suboptimal contrast opacification, branch ostium cannot be shown clearly, severe overlap in the stenosed segment or severe tortuosity of any interrogated vessel deemed not amenable to QFR or RWS measurement 2. An interrogated lesion require surgical bypass grafting 3. Unable to judge culprit lesion or infarct-related artery according to current evidence
Where this trial is running
Beijing
- Lei Song — Beijing, China (Recruiting)
Study contacts
- Principal investigator: Lei Song, MD — Chinese Academy of Medical Sciences, Fuwai Hospital
- Study coordinator: Lei Song, MD
- Email: drsong@vip.163.com
- Phone: 01088322564
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.